94 related articles for article (PubMed ID: 17374251)
1. [Criteria for diagnosing well-differentiated endometrioid adenocarcinoma in uterine curettage specimens].
Huang SF
Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):708-10. PubMed ID: 17374251
[No Abstract] [Full Text] [Related]
2. Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens.
Izadi-Mood N; Khaniki M; Irvanloo G; Ahmadi SA; Hayeri H; Meysamie A
Arch Iran Med; 2009 Jul; 12(4):377-82. PubMed ID: 19566355
[TBL] [Abstract][Full Text] [Related]
3. [Is diagnostic curettage sufficient prior to endometrial ablation? Case of an early stage endometrial cancer].
Galo S; Zúbor P; Kajo K; Macháleková K; Szunyogh N; Visnovský J
Ceska Gynekol; 2005 Nov; 70(6):449-52. PubMed ID: 17955798
[TBL] [Abstract][Full Text] [Related]
4. The role of liquid-based cytology associated with curettage in the investigation of endometrial lesions from postmenopausal women.
Papaefthimiou M; Symiakaki H; Mentzelopoulou P; Giahnaki AE; Voulgaris Z; Diakomanolis E; Kyroudes A; Karakitsos P
Cytopathology; 2005 Feb; 16(1):32-9. PubMed ID: 15859313
[TBL] [Abstract][Full Text] [Related]
5. Nuclear features in endometrial cytology: comparison of endometrial glandular and stromal breakdown and endometrioid adenocarcinoma grade 1.
Norimatsu Y; Shigematsu Y; Sakamoto S; Ohsaki H; Yanoh K; Kawanishi N; Kobayashi TK
Diagn Cytopathol; 2012 Dec; 40(12):1077-82. PubMed ID: 22241733
[TBL] [Abstract][Full Text] [Related]
6. Comparison between adenocarcinoma in both endocervical and endometrial specimens from fractional curettage and pathologic findings in subsequent hysterectomy specimens.
Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
J Med Assoc Thai; 2008 Sep; 91(9):1313-7. PubMed ID: 18843857
[TBL] [Abstract][Full Text] [Related]
7. Ciliated Carcinoma of the Endometrium.
Guerrieri C; Anderson P; Hudacko R
Int J Gynecol Pathol; 2021 Mar; 40(2):141-147. PubMed ID: 32897959
[TBL] [Abstract][Full Text] [Related]
8. [Endometrial cancer, turned out to be an endometroid ovarian cancer stage II].
Lazarov N; Lazarov L; Laarov S; Velev V; Ananiev J
Akush Ginekol (Sofiia); 2011; 50(6):48-50. PubMed ID: 22452068
[TBL] [Abstract][Full Text] [Related]
9. [Status of fractionated abrasion and vaginal endocervical cytology in diagnosis of endometrial cancer].
Schild R; Kutta T
Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):467-70. PubMed ID: 1397942
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of endometrial curettage in endometrial pathology.
Saadia A; Mubarik A; Zubair A; Jamal S; Zafar A
J Ayub Med Coll Abbottabad; 2011; 23(1):129-31. PubMed ID: 22830167
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of hysteroscopy: correlation with histological findings after dilatation and curettage and hysterectomy.
Piccolboni G; Arlacchi E; Cattani P; Zardini R; Lavanda E; Zardini E
Acta Eur Fertil; 1991; 22(4):233-4. PubMed ID: 1844329
[TBL] [Abstract][Full Text] [Related]
12. Does hysteroscopy improve upon the sensitivity of dilatation and curettage in the diagnosis of endometrial hyperplasia or carcinoma?
Ben-Yehuda OM; Kim YB; Leuchter RS
Gynecol Oncol; 1998 Jan; 68(1):4-7. PubMed ID: 9454651
[TBL] [Abstract][Full Text] [Related]
13. IMP2 expression distinguishes endometrioid from serous endometrial adenocarcinomas.
Zhang L; Liu Y; Hao S; Woda BA; Lu D
Am J Surg Pathol; 2011 Jun; 35(6):868-72. PubMed ID: 21566514
[TBL] [Abstract][Full Text] [Related]
14. The Time Has Come to Quit Relying on a Blind Endometrial Biopsy or Dilation and Curettage to Rule Out Malignant Endometrial Changes.
Loffer FD
J Minim Invasive Gynecol; 2019; 26(7):1207-1208. PubMed ID: 30980989
[No Abstract] [Full Text] [Related]
15. Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium.
Garg K; Soslow RA
Adv Anat Pathol; 2012 Jan; 19(1):1-10. PubMed ID: 22156830
[TBL] [Abstract][Full Text] [Related]
16. [Lobular carcinoma of the breast detected and diagnosed by means of probative curettage biopsy of the endometrium].
Zavadil M; Zavadilová H
Ceska Gynekol; 1995 Jun; 60(3):160-2. PubMed ID: 7670710
[No Abstract] [Full Text] [Related]
17. Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.
Yasuda M
J Obstet Gynaecol Res; 2014 Dec; 40(12):2167-76. PubMed ID: 25363801
[TBL] [Abstract][Full Text] [Related]
18. Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer.
Kim MK; Seong SJ; Song T; Kim ML; Yoon BS; Jun HS; Lee GH; Lee YH
Gynecol Oncol; 2013 Sep; 130(3):470-3. PubMed ID: 23822890
[TBL] [Abstract][Full Text] [Related]
19. Clear Cell Lesions of the Mullerian System: Not Always That "Clear"!
Wawire J; Lawrence WD; Quddus MR
Int J Surg Pathol; 2019 Dec; 27(8):884-886. PubMed ID: 30917732
[No Abstract] [Full Text] [Related]
20. Pipelle versus fractional curettage for the endometrial sampling in postmenopausal women.
Bunyavejchevin S; Triratanachat S; Kankeow K; Limpaphayom KK
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S326-30. PubMed ID: 11529353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
